GLP-1 'fat-loss stacks': what the science actually supports

What did @tonyhuge.official actually say?

Tony Huge promoted four compounds as the ultimate fat-loss combination: tesofensine, 5-amino-1MQ, SLUPP332, and carnitine. His pitch is that these compounds together "incinerate body fat" while preserving muscle, boosting metabolic efficiency, and converting stored fat into fuel during workouts. He frames it as insider knowledge: "they don't want you to know about this one." That framing is a red flag before we even look at the compounds themselves.

Three of the four substances he named are either experimental research chemicals, not approved for human use, or have a very thin clinical evidence base. The fourth, carnitine, is a legitimate and widely studied supplement, though its fat-loss effects are far more modest than "making every workout twice as effective." The stack as a whole has never been tested in combination in any published human trial.

Does the science back this up?

Partially, but mostly no. Tesofensine has actual clinical trial data behind it. The other three compounds are at various stages between animal research and theoretical biochemistry. Presenting them as an established "stack" misrepresents how drug development actually works.

Tesofensine, a triple monoamine reuptake inhibitor originally developed for Parkinson's and Alzheimer's disease, did show meaningful weight loss in a Phase 2 trial. Astrup et al. (2008, Lancet) found 0.5 mg/day produced roughly 10.6% body weight reduction over 24 weeks compared to 2.2% with placebo. That is real. But it also raised heart rate and blood pressure significantly, and it never made it through Phase 3 trials. It is not approved anywhere for weight loss.

5-amino-1MQ is a small molecule NNMT inhibitor. The preclinical work from Neelakantan et al. (2019, Nature Communications) is interesting, showing fat mass reduction in mice. There are no published human trials. SLUPP332 is a PPARdelta agonist studied in rodents only. Narkar et al. (2008, Cell) showed endurance improvements in mice, but this compound has never been tested in humans in any peer-reviewed published study.

What did they get wrong (or right)?

He got tesofensine partly right and carnitine mostly wrong. The rest is speculation dressed up as certainty.

On tesofensine: calling it something that "curbs your appetite, torches fat, and gives you clean, lasting energy" is a selective reading. The Lancet data does support appetite suppression and weight loss. The cardiovascular side effects, including tachycardia and elevated blood pressure, are not mentioned. For someone stacking this with stimulant-adjacent compounds, that omission is not a minor oversight.

On carnitine: it is not the "endurance king" that "converts stored fat into fuel" in any dramatic sense. A systematic review by Pooyandjoo et al. (2016, Obesity Reviews) found modest body weight reductions in supplemented groups, but the effect sizes were small and most studies were in sedentary or elderly populations. Telling a fitness audience it makes "every workout twice as effective at shredding stubborn fat" is not supported by the data.

On 5-amino-1MQ and SLUPP332: presenting mouse-model research chemicals as ready-to-use human fat-loss compounds is genuinely irresponsible. These are not supplements. They are experimental molecules.

What should you actually know?

If you are seriously interested in evidence-based fat loss, the compounds with the strongest human clinical data are GLP-1 receptor agonists, not research chemicals promoted on TikTok. Semaglutide and tirzepatide have Phase 3 trial data, FDA approval, and long-term safety follow-up that none of these four compounds have.

That does not mean tesofensine or NNMT inhibitors are worthless science. It means they are not ready for self-administration, especially not in a stack with no human combination data. The "they don't want you to know" framing also deserves pushback: pharmaceutical and academic researchers are actively studying metabolic compounds. The reason these specific ones are not available is not suppression. It is that they have not cleared the clinical bar yet.

Stacking multiple compounds with overlapping CNS or cardiovascular effects without medical supervision is a real risk. If you are considering any pharmacological approach to fat loss, that conversation belongs with a licensed clinician who can review your cardiovascular history, not a TikTok comment section.